Fellowbook News

Plug-and-play organ-on-a-chip can be customized to the patient

Engineered tissues have become a critical component for modeling diseases and testing the efficacy and safety of drugs in a human context. A major challenge for researchers has been how to model body functions and systemic diseases with multiple engineered tissues that can physiologically communicate — just like they do in the body. However, it is essential to provide each engineered tissue with its own environment so that the specific tissue phenotypes can be maintained for weeks to months, as required for biological and biomedical studies. Making the challenge even more complex is the necessity of linking the tissue modules together to facilitate their physiological communication, which is required for modeling conditions that involve more than one organ system, without sacrificing the individual engineered tissue environments.

Novel plug-and-play multi-organ chip, customized to the patient

Up to now, no one has been able to meet both conditions. Today, a team of researchers from Columbia Engineering and Columbia University Irving Medical Center reports that they have developed a model of human physiology in the form of a multi-organ chip consisting of engineered human heart, bone, liver, and skin that are linked by vascular flow with circulating immune cells, to allow recapitulation of interdependent organ functions. The researchers have essentially created a plug-and-play multi-organ chip, which is the size of a microscope slide, that can be customized to the patient. Because disease progression and responses to treatment vary greatly from one person to another, such a chip will eventually enable personalized optimization of therapy for each patient. The study is the cover story of the April 2022 issue of Nature Biomedical Engineering… Continue reading.

 

Why inflammation persists in cystic fibrosis—even after CFTR correction
Chronic lung inflammation in cystic fibrosis (CF) often persists even after treatment with newly-approved gene therapies or small molecule CFTR modulators—an unresolved clinical paradox. A new study published in EXO – Beyond the Cell identifies...
Tiny killers: How autoantibodies attack the heart in lupus patients
Columbia team engineers a model of the human heart tissue that demonstrates how autoantibodies directly affect heart disease in lupus patients Cardiovascular disease is the leading cause of death in patients suffering from lupus, an autoimmune disease...
A lung-mimicking sealant helps repair surgical leaks
A superior surgical sealant mimics the structural and mechanical properties of lung tissue to repair air leaks after surgery. A new sealant meant to mimic lung tissue has been shown to rapidly cork air leaks following surgery. Moreover, the protein-like...
Tissue chip developments: what’s the 411?
Tissue chips—tiny mimics of human organs, just millimeters in size—represent an alternative to animal models as a way to study disease or evaluate drugs. However, a major limitation of tissue chips is that they do not faithfully imitate tissue interactions,...
Gordana Vunjak-Novakovic Receives AIMBE’s Highest Award
AIMBE is honored to recognize Gordana Vunjak-Novakovic with its Pierre Galletti Award, the Institute’s highest accolade. Including years of contributions to AIMBE and the BME community, Vunjak-Novakovic is recognized for impactful innovations in technologies...